Literature DB >> 26851652

Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).

Linghai Kong1, Rebecca Albano1, Aric Madayag1, Nicholas Raddatz1, John R Mantsch1, SuJean Choi1, Doug Lobner1, David A Baker1.   

Abstract

Glutamate signaling is achieved by an elaborate network involving neurons and astrocytes. Hence, it is critical to better understand how neurons and astrocytes interact to coordinate the cellular regulation of glutamate signaling. In these studies, we used rat cortical cell cultures to examine whether neurons or releasable neuronal factors were capable of regulating system xc (-) (Sxc), a glutamate-releasing mechanism that is expressed primarily by astrocytes and has been shown to regulate synaptic transmission. We found that astrocytes cultured with neurons or exposed to neuronal-conditioned media displayed significantly higher levels of Sxc activity. Next, we demonstrated that the pituitary adenylate cyclase-activating polypeptide (PACAP) may be a neuronal factor capable of regulating astrocytes. In support, we found that PACAP expression was restricted to neurons, and that PACAP receptors were expressed in astrocytes. Interestingly, blockade of PACAP receptors in cultures comprised of astrocytes and neurons significantly decreased Sxc activity to the level observed in purified astrocytes, whereas application of PACAP to purified astrocytes increased Sxc activity to the level observed in cultures comprised of neurons and astrocytes. Collectively, these data reveal that neurons coordinate the actions of glutamate-related mechanisms expressed by astrocytes, such as Sxc, a process that likely involves PACAP. A critical gap in modeling excitatory signaling is how distinct components of the glutamate system expressed by neurons and astrocytes are coordinated. In these studies, we found that system xc (-) (Sxc), a glutamate release mechanism expressed by astrocytes, is regulated by releasable neuronal factors including PACAP. This represents a novel form of neuron-astrocyte communication, and highlights the possibility that pathological changes involving astrocytic Sxc may stem from altered neuronal activity.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  PACAP; astrocyte; cystine; glutamate; neuron-astrocyte interaction; system xc−

Mesh:

Substances:

Year:  2016        PMID: 26851652      PMCID: PMC4878137          DOI: 10.1111/jnc.13566

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  103 in total

Review 1.  Translating glutamate: from pathophysiology to treatment.

Authors:  Daniel C Javitt; Darryle Schoepp; Peter W Kalivas; Nora D Volkow; Carlos Zarate; Kalpana Merchant; Mark F Bear; Daniel Umbricht; Mihaly Hajos; William Z Potter; Chi-Ming Lee
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

Review 2.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

3.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

Authors:  B Moghaddam; B W Adams
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

4.  Sustained neuronal activity generated by glial plasticity.

Authors:  Tiina M Pirttimaki; Stephen D Hall; H Rheinallt Parri
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 5.  Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.

Authors:  Khaled Moussawi; Peter W Kalivas
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

6.  Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse.

Authors:  Khaled Moussawi; Wenhua Zhou; Haowei Shen; Carmela M Reichel; Ronald E See; David B Carr; Peter W Kalivas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

7.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

Review 8.  Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.

Authors:  Douglas J Roberts-Wolfe; Peter W Kalivas
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

9.  Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ.

Authors:  L Pasti; A Volterra; T Pozzan; G Carmignoto
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  9 in total

1.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

2.  Pituitary adenylate cyclase-activating polypeptide receptor activation in the hypothalamus recruits unique signaling pathways involved in energy homeostasis.

Authors:  Brian Maunze; Katherine Wood Bruckner; Nikhil Nilesh Desai; Christopher Chen; Fanghong Chen; David Baker; SuJean Choi
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-01-10       Impact factor: 4.310

3.  Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Authors:  Maju Mathew Koola; Samir Kumar Praharaj; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2019-05-17

4.  Pituitary Adenylate-Cyclase Activating Polypeptide Regulates Hunger- and Palatability-Induced Binge Eating.

Authors:  Matthew M Hurley; Brian Maunze; Megan E Block; Mogen M Frenkel; Michael J Reilly; Eugene Kim; Yao Chen; Yan Li; David A Baker; Qing-Song Liu; SuJean Choi
Journal:  Front Neurosci       Date:  2016-08-22       Impact factor: 4.677

5.  Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss.

Authors:  Jérôme Ruel; Matthieu J Guitton; Paul Gratias; Marc Lenoir; Sanbing Shen; Jean-Luc Puel; Philippe Brabet; Jing Wang
Journal:  Front Cell Neurosci       Date:  2021-03-22       Impact factor: 5.505

6.  Validation of a System xc - Functional Assay in Cultured Astrocytes and Nervous Tissue Samples.

Authors:  Pauline Beckers; Olaya Lara; Ines Belo do Nascimento; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Front Cell Neurosci       Date:  2022-01-13       Impact factor: 5.505

7.  Shorebirds' Longer Migratory Distances Are Associated With Larger ADCYAP1 Microsatellites and Greater Morphological Complexity of Hippocampal Astrocytes.

Authors:  Diego de Almeida Miranda; Juliana Araripe; Nara G de Morais Magalhães; Lucas Silva de Siqueira; Cintya Castro de Abreu; Patrick Douglas Corrêa Pereira; Ediely Pereira Henrique; Pedro Arthur Campos da Silva Chira; Mauro A D de Melo; Péricles Sena do Rêgo; Daniel Guerreiro Diniz; David Francis Sherry; Cristovam W P Diniz; Cristovam Guerreiro-Diniz
Journal:  Front Psychol       Date:  2022-02-04

8.  Prefrontal cortex PACAP signaling: organization and role in stress regulation.

Authors:  Susan E Martelle; Evelin M Cotella; Nawshaba Nawreen; Carrie Chen; Benjamin A Packard; Maureen Fitzgerald; James P Herman
Journal:  Stress       Date:  2021-03-17       Impact factor: 3.493

9.  Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes.

Authors:  Jeffrey R Jones; Linghai Kong; Michael G Hanna; Brianna Hoffman; Robert Krencik; Robert Bradley; Tracy Hagemann; Jeea Choi; Matthew Doers; Marina Dubovis; Mohammad Amin Sherafat; Anita Bhattacharyya; Christina Kendziorski; Anjon Audhya; Albee Messing; Su-Chun Zhang
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.